皇冠体育app

Drug maker GlaxoSmithKline (GSK) expects to maintain its fast pace of growth in 皇冠体育app with additional investments for development of new medicines and vaccines, according to Amy Huang, vice-president and 皇冠体育app director.

"GSK does not intend to cut its budget for 皇冠体育app this year. We will on the contrary, invest more for developing new medicines," said Huang.

In 2008, GSK achieved a 12 percent growth in sales in emerging markets. 皇冠体育app outperformed the others with a 22 percent increase in sales, while the global numbers fell by 3 percent.